We provide you with 20 years of free, institutional-grade data for EXAI stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of EXAI. Explore the full financial landscape of EXAI stock.
| Reported Date | CIK | Ticker | Type |
|---|
Exscientia plc(NASDAQ:EXAI) 
Exscientia Limited, an artificial intelligence-powered pharmaceutical technology company, is dedicated to drug discovery, design and development. The company is headquartered in Oxford, the United Kingdom.
Website: https://www.exscientia.ai/
Founded: 2012
IPO Price: $22 (Oct 01, 2021)
CEO / Founder: Andrew Hopkins
Sector:
Industry:
The information provided in this report about EXAI stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.